Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas-Reference-Cited by-同舟云学术

Differential expression of 12 histone deacetylase (HDAC) genes in astrocytomas and normal brain tissue: class II and IV are hypoexpressed in glioblastomas

Published:2008-08-19 Issue:1 Volume:8 Page:
ISSN:1471-2407
Container-title:BMC Cancer
language:en
Short-container-title:BMC Cancer

Author:

Lucio-Eterovic Agda KB,Cortez Maria AA,Valera Elvis T,Motta Fabio JN,Queiroz Rosane GP,Machado Helio R,Carlotti Carlos G,Neder Luciano,Scrideli Carlos A,Tone Luiz G

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics,Oncology

Link

http://link.springer.com/content/pdf/10.1186/1471-2407-8-243.pdf

Reference45 articles.

1. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P: The 2007 WHO classification of tumours of the central nervous system. Acta neuropathologica. 2007, 114 (2): 97-109. 10.1007/s00401-007-0243-4.

2. Lin HY, Chen CS, Lin SP, Weng JR, Chen CS: Targeting histone deacetylase in cancer therapy. Medicinal research reviews. 2006, 26 (4): 397-413. 10.1002/med.20056.

3. Wade PA: Transcriptional control at regulatory checkpoints by histone deacetylases: molecular connections between cancer and chromatin. Human molecular genetics. 2001, 10 (7): 693-698. 10.1093/hmg/10.7.693.

4. Gray SG, Ekstrom TJ: The human histone deacetylase family. Experimental cell research. 2001, 262 (2): 75-83. 10.1006/excr.2000.5080.

5. Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkuhler C: HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Cell research. 2007, 17 (3): 195-211.

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Epigenetic Modifiers HDAC2 and HDAC7 Inversely Associate with Cancer Stemness and Immunity in Solid Tumors;International Journal of Molecular Sciences;2024-07-17

2. High-throughput RNA-Seq and In-silico analysis ofglioblastoma cells treated with cold atmosphericplasma and temozolomide.;2024-07-01

3. High-throughput RNA-Seq and In-silico analysis of glioblastoma cells treated with cold atmospheric plasma and temozolomide.;2024-06-20

4. Understanding the immunosuppressive microenvironment of glioma: mechanistic insights and clinical perspectives;Journal of Hematology & Oncology;2024-05-08

5. Mocetinostat as a novel selective histone deacetylase (HDAC) inhibitor in the promotion of apoptosis in glioblastoma cell line C6 and T98G;2024-04-01